| 000 | 01581 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515232246.0 | ||
| 264 | 0 | _c20101018 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1096-9896 | ||
| 024 | 7 |
_a10.1002/path.2744 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKöbel, Martin | |
| 245 | 0 | 0 |
_aThe biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. _h[electronic resource] |
| 260 |
_bThe Journal of pathology _cOct 2010 |
||
| 300 |
_a191-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCystadenocarcinoma, Serous _xgenetics |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aReuss, Alexander | |
| 700 | 1 | _adu Bois, Andreas | |
| 700 | 1 | _aKommoss, Stefan | |
| 700 | 1 | _aKommoss, Friedrich | |
| 700 | 1 | _aGao, Dongxia | |
| 700 | 1 | _aKalloger, Steve E | |
| 700 | 1 | _aHuntsman, David G | |
| 700 | 1 | _aGilks, C Blake | |
| 773 | 0 |
_tThe Journal of pathology _gvol. 222 _gno. 2 _gp. 191-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.2744 _zAvailable from publisher's website |
| 999 |
_c19971896 _d19971896 |
||